CompanyGraph
What stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onUpstream position: supplies 8 industries, depends on 0
- ScaleMarket cap is $2.53B, above the global median of $1.15B
- PositionDebt-to-equity is 3.55×, higher than 95% of its Conglomerates peers (median 0.38×)
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
44.98TIDR2.53B · vs all stocks (USD)
Trailing P/E
47.27xvs Conglomerates peers
Revenue (TTM)
3.92TIDR220.67M · vs all stocks (USD)
Profit Margin
11.44%vs Conglomerates peers
Beta
1.28xvs all stocks
52-Week Change
171.05%vs all stocks
Market Capitalization
44.98TIDR2.53B · vs all stocks (USD)
Enterprise Value
34.04TIDR1.91B · vs all stocks (USD)
Trailing P/E
47.27xvs Conglomerates peers
PEG Ratio
-0.4941xvs Conglomerates peers
Price to Sales (TTM)
11.57xvs Conglomerates peers
Price to Book (MRQ)
4.66xvs Conglomerates peers
Enterprise to Revenue
8.68xvs Conglomerates peers
Enterprise to EBITDA
74.25xvs Conglomerates peers
Gross Margin
33.01%vs Conglomerates peers
Profit Margin
11.44%vs Conglomerates peers
Operating Margin
18.67%vs Conglomerates peers
Return on Assets (TTM)
0.71%vs Conglomerates peers
Return on Equity (TTM)
10.57%vs Conglomerates peers
Revenue (TTM)
3.92TIDR220.67M · vs all stocks (USD)
Revenue per Share (TTM)
22.63IDRUpdated Aug 21, 2026Quarterly Revenue Growth
19.00%vs Conglomerates peers
Gross Profit (TTM)
898.23BIDR50.51M · vs all stocks (USD)
EBITDA (TTM)
515.59BIDR28.99M · vs all stocks (USD)
Net Income (TTM)
448.77BIDR25.23M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-78.20%vs Conglomerates peers
Operating Cash Flow (TTM)
-265.17BIDR-14.91M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-983.77BIDR-55.32M · vs all stocks (USD)
Payout Ratio
0.00%vs Conglomerates peers
Minority Interest (Equity)
818.49BIDRFY2025 · Dec 31, 2025Revenue
3.74TIDRFY2025 · Dec 31, 2025Cost of Goods Sold
3.00TIDRFY2025 · Dec 31, 2025Gross Profit
744.38BIDRFY2025 · Dec 31, 2025Operating Income
110.58BIDR6.22M · vs all stocks (USD)
Pre-tax Income
518.83BIDRFY2025 · Dec 31, 2025Income Tax Expense
16.09BIDRFY2025 · Dec 31, 2025Net Income
502.74BIDRFY2025 · Dec 31, 2025EBIT
813.77BIDRFY2025 · Dec 31, 2025EBITDA (Income Statement)
615.63BIDRFY2025 · Dec 31, 2025Selling, General & Administrative
178.77BIDRFY2025 · Dec 31, 2025Other Operating Expenses
137.70BIDRFY2025 · Dec 31, 2025Non-operating Interest Income
93.54BIDRFY2025 · Dec 31, 2025Non-operating Interest Expense
294.94BIDRFY2025 · Dec 31, 2025Minority Interests (P&L)
-8.89BIDRFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00IDRFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
236.65BIDRFY2025 · Dec 31, 2025Capital Expenditures
-183.30BIDRFY2025 · Dec 31, 2025Net Intangibles (CF)
-9.28BIDRFY2025 · Dec 31, 2025Net Acquisitions
-3.28TIDRFY2025 · Dec 31, 2025Purchase of Investments
-1.15TIDRFY2025 · Dec 31, 2025Sale of Investments
3.58BIDRFY2025 · Dec 31, 2025Other Investing Activity
-709.67BIDRFY2025 · Dec 31, 2025Net Investing Cash Flow
-5.33TIDRFY2025 · Dec 31, 2025Long-term Debt Issuance
4.87TIDRFY2025 · Dec 31, 2025Long-term Debt Payments
-1.92TIDRFY2025 · Dec 31, 2025Net Short-term Debt Issuance
1.05TIDRFY2025 · Dec 31, 2025Other Financing Charges
-267.32BIDRFY2025 · Dec 31, 2025Net Financing Cash Flow
3.73TIDRFY2025 · Dec 31, 2025Shares Outstanding
173.42BSharesUpdated Aug 21, 2026% Held by Insiders
51.57%vs all stocks
% Held by Institutions
0.01%vs all stocks
Total Cash (MRQ)
1.53TIDR85.92M · vs all stocks (USD)
Total Cash per Share (MRQ)
8.81IDRUpdated Aug 21, 2026Total Debt (MRQ)
17.24TIDR969.38M · vs all stocks (USD)
Total Debt to Equity (MRQ)
3.55xvs Conglomerates peers
Current Ratio (MRQ)
1.31xvs Conglomerates peers
Book Value per Share (MRQ)
22.31IDRUpdated Aug 21, 2026Total Assets
23.57TIDR1.33B · vs all stocks (USD)
Total Current Assets
4.42TIDRFY2025 · Dec 31, 2025Total Liabilities
18.90TIDRFY2025 · Dec 31, 2025Total Non-current Assets
19.15TIDRFY2025 · Dec 31, 2025Total Non-current Liabilities
15.30TIDRFY2025 · Dec 31, 2025Total Current Liabilities
3.60TIDRFY2025 · Dec 31, 2025Cash
236.10BIDRFY2025 · Dec 31, 2025Cash Equivalents
551.00MIDRFY2025 · Dec 31, 2025Cash & Cash Equivalents
236.65BIDRFY2025 · Dec 31, 2025Other Short-term Investments
1.32TIDRFY2025 · Dec 31, 2025Accounts Receivable
409.19BIDRFY2025 · Dec 31, 2025Inventory
626.37BIDRFY2025 · Dec 31, 2025Accounts Payable
906.99BIDRFY2025 · Dec 31, 2025Short-term Debt
2.19TIDRFY2025 · Dec 31, 2025Long-term Debt
14.56TIDRFY2025 · Dec 31, 2025Common Stock (Book)
4.76TIDRFY2025 · Dec 31, 2025Retained Earnings
821.44BIDRFY2025 · Dec 31, 2025Total Shareholders' Equity
4.67TIDR262.69M · vs all stocks (USD)
52-Week Low
31.00IDRUpdated Aug 21, 202652-Week High
264.00IDRUpdated Aug 21, 202652-Week Change
171.05%vs all stocks
Beta
1.28xvs all stocks
50-Day MA
95.88IDRUpdated Aug 21, 2026200-Day MA
121.85IDRUpdated Aug 21, 2026Avg 10-Day Volume
2.15BSharesUpdated Aug 21, 2026Avg 30-Day Volume
2.42BSharesUpdated Aug 21, 2026Diluted EPS (TTM)
2.20IDRUpdated Aug 21, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Long-Term Debt A High Share Of Total Liabilities, Short-Term Debt A High Share Of Current Liabilities
Borrowing makes up most of what it owes, both the long-dated part and the part due soon.
Reads
Intangible Concentration
Much of what it owns is goodwill from past deals, large next to its equity.
Reads
How does this company use capital?
Diagnostic
Elevated ROE With High Debt-to-Equity and Equity Multiplier
Return on equity reads high on a balance sheet carrying a lot of debt against that equity.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Debt-to-equity is 3.55×, higher than 95% of its Conglomerates peers (median 0.38×)Significant
Debt-to-equity: 3.55Industry median: 0.38Industry P95: 2.41Peers compared: 104
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 25,234,111.324Operating Cash Flow (USD, TTM): -14,910,340.154
Financial Health
Altman Z-Score 1.79: grey zoneSignificant
Altman Z-Score: 1.79
Supply Chain
Upstream position: supplies 8 industries, depends on 0Notable
Outgoing: 8.00Incoming: 0.00
Scale
Market cap is $2.53B, above the global median of $1.15BNotable
Market cap (USD): 2,529,428,686.986Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Astrana Health Inc.
Tier 1RiskThroughput-Bound ConversionProductionFlow
China Baoan Group Co. Ltd.
Tier 1RiskThroughput-Bound ConversionProductionInterface
Shanghai Industrial Holdings Limited
Tier 1RiskThroughput-Bound ConversionProductionFlow
Massachusetts Port Authority Revenue Bonds, AMT Series A
Tier 1RiskThroughput-Bound ConversionFlowRule
Fosun International Limited
Tier 1RiskThroughput-Bound ConversionProductionFlow
Aamal Company Q.P.S.C.
Tier 1RiskThroughput-Bound ConversionProductionFlow
Shenzhen Best of Best Holding Co., Ltd.
Tier 1RiskThroughput-Bound ConversionInterfaceProduction
Dogan Sirketler Grubu Holdings A.S.
Tier 1RiskThroughput-Bound ConversionAttentionProduction
Xplr Infrastructure Partners L.P.
Tier 1RiskThroughput-Bound ConversionInterfaceProduction
Ampa Limited
Tier 1RiskThroughput-Bound ConversionInterfaceProduction
Companies that share active interpretations — structural patterns currently present in both stocks.
Global Yatırım Holding A.Ş.
3 interpretationsLong-Term Debt A High Share Of Total Liabilities, Short-Term Debt A High Share Of Current LiabilitiesIntangible ConcentrationElevated ROE With High Debt-to-Equity and Equity Multiplier
F-Secure Oyj
2 interpretationsIntangible ConcentrationElevated ROE With High Debt-to-Equity and Equity Multiplier
Halozyme Therapeutics Inc.
2 interpretationsIntangible ConcentrationElevated ROE With High Debt-to-Equity and Equity Multiplier